PROTEK

Protek is a company that includes drug manufacturing, retail, and distribution. It is one of the largest pharmaceutical companies of Russia. PROTEK Group has a diversified business structure and operates in all major segments of the pharmaceutical industry: production of medicines, distribution of pharmaceuticals and health and beauty products, as well as retail sales. He manages the retail pharmacy chain Rigla.
P/E
Net profit
P/B
Book value
Debts
Net debt
Yield
Growth potential

PROTEK balance sheet

Report period2014 2015 2016 2017 2018 2019
Capitalization, ₽
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

PROTEK cash flows

Report period2014 2015 2016 2017 2018 2019
Sales
Operation Income
Earnings
Shareholders earnings
EBITDA
EPS

PROTEK multipliers

Report period2014 2015 2016 2017 2018 2019
P/E
E/P
P/B
P/S
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

PROTEK profitability

Report period2014 2015 2016 2017 2018 2019
ROA
ROE
ROS
EBITDA Margin
Operating margin
PROTEK assets
PROTEK cash flows
Share capital structure of PROTEK
PROTEK news
09.06.2020
PROTEK shareholders decided not to pay dividends for 2019.
04.06.2020
In connection with the request of CJSC PROTEK Implementation Center to repurchase the shares of PJSC PROTEK, the Moscow Exchange decided to limit the settlement codes when submitting applications to conclude transactions with the company's securities. Thus, from June 05, 2020 settlement codes providing for the execution of transactions no later than July 16,...
Source: {source} pictogram moex.com
04.06.2020
PROTEK has received a request from the PROTEK Implementation Centre CJSC, which holds a 99.52% stake in the charter capital of a pharmaceutical company, to buy back its shares from the other shareholders at ₽100 for paper. The list of owners of redeemable securities will be determined as of July 20, 2020.
13.05.2020
PROTEK's net profit under RAS for 3 months. 2020 amounted to ₽1 039.997 mln, against a loss of ₽50.3 mln in the previous year. Revenue decreased by 30.9% to ₽112,982 mln against ₽163,441 mln a year earlier.
General information
Company namePROTEK
Tags#pharmacy
SectorConsumer Staples / Food & Staples Retailing / Food & Staples Retailing / Drug Retail
Business address115201, RF, g. Moskva, Kashirskoe shosse, d. 22, korp. 4
Mailing address127282, RF, g. Moskva, ul. Chermyanskaya, d.2
CEOMuzyaev Vadim Gennadievich
Phone+(7-495) 730-78-40
Websitewww.protek-group.ru
Information disclosuree-disclosure.ru